Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 13/20 | 0.49 |
| ▸ | JAK3 | P52333 | 12/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | BCL6 | P41182 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4969755 | 0.87 | JAK2 (0.50) | JAK2JAK3SMN1; SMN2MAPK1NPC1 | |
| SCHEMBL4972182 | 0.84 | JAK2 (0.48) | JAK2JAK3SMN1; SMN2MAPK1NPC1 | |
| SCHEMBL4975407 | 0.83 | JAK2 (0.46) | JAK2JAK3SMN1; SMN2BCL6NPC1 | |
| SCHEMBL4972221 | 0.81 | JAK2 (0.61) | JAK2JAK3SMN1; SMN2BCL6KDM4E | |
| SCHEMBL4972548 | 0.81 | JAK2 (0.46) | JAK2JAK3SMN1; SMN2MAPK1 | |
| SCHEMBL4974705 | 0.81 | JAK2 (0.49) | JAK2JAK3SMN1; SMN2MAPK1BCL6 | |
| SCHEMBL13494472 | 0.81 | JAK2 (0.53) | JAK2JAK3 | |
| SCHEMBL4974714 | 0.79 | JAK2 (0.47) | JAK2JAK3SMN1; SMN2MAPK1BCL6 | |
| SCHEMBL4970845 | 0.75 | JAK2 (0.64) | JAK2JAK3SMN1; SMN2MAPK1BCL6 | |
| SCHEMBL4980198 | 0.74 | JAK2 (0.64) | JAK2JAK3SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008132502-A1 | PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2008-11-06 | — | — | WO | disclosed |